TENX
Tenax Therapeutics Inc
Halal Rating :
Last Price
$6.26
Last updated:
Market Cap
-
7D Change
1.62%
1 Year Change
-35.4%
Company Overview
Industries
Exchange
Next Earnings Date
Tenax Therapeutics Inc is a specialty pharmaceutical company focused on developing and commercializing products for the critical care market. The company is developing TNX-103 (oral levosimendan) for the treatment of Pulmonary Hypertension with Heart Failure with Preserved Ejection Fraction (PH-HFpEF) and TNX-102 (IV imatinib) for the treatment of Pulmonary Arterial Hypertension (PAH).
Use of Interest
| Reporting Date | Total Revenue | Total Operating Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|
Company Impact
Help us evaluate Tenax Therapeutics Inc's impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.